JP2011148817A5 - - Google Patents

Download PDF

Info

Publication number
JP2011148817A5
JP2011148817A5 JP2011061926A JP2011061926A JP2011148817A5 JP 2011148817 A5 JP2011148817 A5 JP 2011148817A5 JP 2011061926 A JP2011061926 A JP 2011061926A JP 2011061926 A JP2011061926 A JP 2011061926A JP 2011148817 A5 JP2011148817 A5 JP 2011148817A5
Authority
JP
Japan
Prior art keywords
boron
following formula
trifluoride
benzoyl
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011061926A
Other languages
English (en)
Japanese (ja)
Other versions
JP5351919B2 (ja
JP2011148817A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011148817A publication Critical patent/JP2011148817A/ja
Publication of JP2011148817A5 publication Critical patent/JP2011148817A5/ja
Application granted granted Critical
Publication of JP5351919B2 publication Critical patent/JP5351919B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011061926A 2004-07-21 2011-03-22 アルキル置換された2−デオキシ−2−フルオロ−d−リボフラノシルピリミジン類及びプリン類及びそれらの誘導体の調製 Expired - Lifetime JP5351919B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58986604P 2004-07-21 2004-07-21
US60/589,866 2004-07-21
US60823004P 2004-09-09 2004-09-09
US60/608,230 2004-09-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007522763A Division JP5078612B2 (ja) 2004-07-21 2005-07-21 アルキル置換された2−デオキシ−2−フルオロ−d−リボフラノシルピリミジン類及びプリン類及びそれらの誘導体の調製

Publications (3)

Publication Number Publication Date
JP2011148817A JP2011148817A (ja) 2011-08-04
JP2011148817A5 true JP2011148817A5 (https=) 2011-12-08
JP5351919B2 JP5351919B2 (ja) 2013-11-27

Family

ID=35786706

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007522763A Expired - Lifetime JP5078612B2 (ja) 2004-07-21 2005-07-21 アルキル置換された2−デオキシ−2−フルオロ−d−リボフラノシルピリミジン類及びプリン類及びそれらの誘導体の調製
JP2011061926A Expired - Lifetime JP5351919B2 (ja) 2004-07-21 2011-03-22 アルキル置換された2−デオキシ−2−フルオロ−d−リボフラノシルピリミジン類及びプリン類及びそれらの誘導体の調製

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007522763A Expired - Lifetime JP5078612B2 (ja) 2004-07-21 2005-07-21 アルキル置換された2−デオキシ−2−フルオロ−d−リボフラノシルピリミジン類及びプリン類及びそれらの誘導体の調製

Country Status (16)

Country Link
EP (2) EP1773856B1 (https=)
JP (2) JP5078612B2 (https=)
KR (2) KR101236669B1 (https=)
CN (1) CN102199181B (https=)
AT (1) ATE543789T1 (https=)
AU (2) AU2005267051B2 (https=)
CA (2) CA2574651C (https=)
DK (1) DK1773856T3 (https=)
ES (1) ES2386005T3 (https=)
IL (2) IL180832A (https=)
MX (1) MX2007000803A (https=)
NZ (1) NZ552927A (https=)
PL (1) PL1773856T3 (https=)
PT (1) PT1773856E (https=)
RU (1) RU2407747C2 (https=)
WO (1) WO2006012440A2 (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
KR20080021797A (ko) 2000-05-26 2008-03-07 이데닉스(케이만)리미티드 플라비바이러스 및 페스티바이러스의 치료방법 및 조성물
NZ537662A (en) 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
PL374781A1 (en) 2002-06-28 2005-10-31 Idenix (Cayman) Limited 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
HUE033832T2 (en) 2002-11-15 2018-01-29 Idenix Pharmaceuticals Llc 2'-methyl nucleosides in combination with interferon and Flaviviridae mutation
RU2005121904A (ru) 2002-12-12 2006-01-20 Айденикс (Кайман) Лимитед (Ky) Способ получения 2`-разветвленных нуклеозидов
EP2345657A1 (en) 2003-05-30 2011-07-20 Pharmasset, Inc. Modified fluorinated nucleoside analogues
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
AU2005285045B2 (en) * 2004-09-14 2011-10-13 Gilead Sciences, Inc. Preparation of 2'fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
US8912321B2 (en) * 2006-10-10 2014-12-16 Gilead Pharmasset Llc Preparation of nucleosides ribofuranosyl pyrimidines
MX2009006156A (es) * 2006-12-18 2009-06-19 Hoffmann La Roche Proceso para preparar 3,5-di-omicron-acil-2-fluoro-2-c-metil-d-rib ono-gamma-lactona.
US20080261913A1 (en) 2006-12-28 2008-10-23 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of liver disorders
WO2008090046A1 (en) * 2007-01-23 2008-07-31 F. Hoffmann-La Roche Ag Alternate process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
PT2376088T (pt) 2008-12-23 2017-05-02 Gilead Pharmasset Llc Fosforamidatos de nucleósidos de 2-amino-purina 6-osubstituída
SG194404A1 (en) * 2008-12-23 2013-11-29 Gilead Pharmasset Llc Synthesis of purine nucleosides
KR20110098849A (ko) 2008-12-23 2011-09-01 파마셋 인코포레이티드 뉴클레오시드 유사체
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI598358B (zh) 2009-05-20 2017-09-11 基利法瑪席特有限責任公司 核苷磷醯胺
PT2609923T (pt) 2010-03-31 2017-08-30 Gilead Pharmasset Llc Processo para a cristalização de 2-(((s)- (perfluorofenoxi)(fenoxi)fosforil)amino)propanoato de (s)-isopropilo
JP5716500B2 (ja) 2010-06-03 2015-05-13 セントラル硝子株式会社 (2R)−2−フルオロ−2−C−メチル−D−リボノ−γ−ラクトン類前駆体の製造方法
AU2011336632B2 (en) 2010-11-30 2015-09-03 Gilead Pharmasset Llc Compounds
EP2691409B1 (en) 2011-03-31 2018-02-21 Idenix Pharmaceuticals LLC. Compounds and pharmaceutical compositions for the treatment of viral infections
EA201391264A1 (ru) 2011-04-13 2014-03-31 Джилид Сайэнс, Инк. 1'-замещенные пиримидиновые n-нуклеозидные аналоги для противовирусного лечения
PL2709613T5 (pl) 2011-09-16 2020-12-14 Gilead Pharmasset Llc Metody leczenia hcv
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
PT2950786T (pt) 2013-01-31 2020-03-03 Gilead Pharmasset Llc Formulação de combinação de dois compostos antivirais
WO2014132975A1 (ja) * 2013-02-28 2014-09-04 セントラル硝子株式会社 (2R)-2-フルオロ-2-C-メチル-D-リボノ-γ-ラクトンの製造方法
JP6476591B2 (ja) * 2013-06-05 2019-03-06 セントラル硝子株式会社 (2R)−2−フルオロ−2−C−メチル−D−リボノ−γ−ラクトン類の製造方法
EA201690473A1 (ru) 2013-08-27 2017-03-31 ГАЙЛИД ФАРМАССЕТ ЭлЭлСи Комбинированный состав двух противовирусных соединений
WO2015097605A1 (en) * 2013-12-23 2015-07-02 Mylan Laboratories Ltd. Process for the preparation of sofosbuvir
WO2016035006A1 (en) * 2014-09-01 2016-03-10 Dr. Reddy’S Laboratories Limited Novel nucleotide analogs, process for the preparation of sofosbuvir and its analogs, novel forms of sofosbuvir and solid dispersion of sofosbuvir
WO2016042576A1 (en) 2014-09-16 2016-03-24 Cadila Healthcare Limited Co-crystal of sofosbuvir and amino acid and process for preparation thereof
CN104327138B (zh) * 2014-10-21 2017-05-10 齐鲁制药有限公司 Psi‑7977中间体化合物的制备方法
USD791845S1 (en) 2015-09-22 2017-07-11 Samsung Electronics Co., Ltd. Door guard for refrigerator
USD791200S1 (en) 2015-09-24 2017-07-04 Samsung Electronics Co., Ltd. Door guard for refrigerator
US10239910B2 (en) 2016-07-20 2019-03-26 Optimus Drugs (P) Limited Process for the preparation of sofosbuvir
CN109422710B (zh) * 2017-08-28 2022-06-21 常州制药厂有限公司 一种索非布韦氟内酯中间体的制备方法
CN111362989B (zh) * 2020-03-19 2022-03-08 江苏工程职业技术学院 一种索非布韦关键中间体的制备方法
WO2021202669A2 (en) 2020-04-01 2021-10-07 Reyoung Corporation Nucleoside and nucleotide conjugate compounds and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
YU25500A (sh) * 1999-05-11 2003-08-29 Pfizer Products Inc. Postupak za sintezu analoga nukleozida
US6462191B1 (en) * 2000-07-13 2002-10-08 Air Products And Chemicals, Inc. Synthesis of 2-deoxy-2-fluoro-arabinose derivatives
WO2002057425A2 (en) * 2001-01-22 2002-07-25 Merck & Co., Inc. Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
JP2005533108A (ja) * 2002-07-16 2005-11-04 メルク エンド カムパニー インコーポレーテッド Rna依存性rnaウイルスポリメラーゼの阻害剤としてのヌクレオシド誘導体
EP2345657A1 (en) * 2003-05-30 2011-07-20 Pharmasset, Inc. Modified fluorinated nucleoside analogues

Similar Documents

Publication Publication Date Title
JP2011148817A5 (https=)
JP2010500343A5 (https=)
JP2009235096A5 (https=)
JP2013518116A5 (https=)
HRP20192203T1 (hr) 3-[4-(7h-pirolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]oktan- ili heptan-nitril kao jak inhibitori
JP2015506356A5 (https=)
RU2014149148A (ru) Способ получения соединений 2-дезокси-2-фтор-2-метил-d-рибофуранозил нуклеозида
JP2010174033A5 (https=)
JP2008525495A5 (https=)
JP2013542261A5 (https=)
RU2013136531A (ru) Способы получения гликосфинголипидов и их применение
RU2014137470A (ru) Способы и соединения, которые можно использовать для синтеза антагонистов рецепторов орексина-2
MY167395A (en) Method for producing glufosinate p free acid
JP2015501820A5 (https=)
RU2016139286A (ru) Способ получения лекарственных средств
RU2012122367A (ru) Способ получения простагландинов и промежуточные соединения для их получения
RU2014145481A (ru) Циклопропанкарбоксилатные эфиры пуриновых аналогов
JP2013528200A5 (https=)
JP2010529994A5 (https=)
JP2014506185A5 (https=)
JP2013520495A5 (https=)
JP2016513128A5 (https=)
JP2009536939A5 (https=)
JP2016503093A5 (https=)
EP2581442A4 (en) METHOD FOR PRODUCING BLOOD-FORMING STEM CELLS